Delivery Order SPE2DB20D1047-SPE2DB25FF83C
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,050.78 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $2,729.66 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by July 24, 2025, with fulfillment occurring at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $26,828.48 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. As a non-set-aside...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,710.33 for Humulin R 500 unit/mL KwikPen 3mL insulin pens on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a $5,348.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The award represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,875.52 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF83CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $9,681.88 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The award was competitively issued with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for insulin products supports the Defense Health Agency and broader military healthcare programs by ensuring access to critical diabetes management medications. AmerisourceBergen's extensive contract portfolio with DLA demonstrates its capability to meet federal procurement requirements through open competition, with delivery orders ranging from minimal values to substantial transactions exceeding $45,000. The company's position as a pharmaceutical prime vendor reflects its operational capacity to supply medical commodities globally and serve diverse federal healthcare customers, including the U.S. Coast Guard and other government health systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/10/25 |